NCT03612596
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Active, not recruiting
Not Applicable
Drug Category: Other
Key Eligibility Criteria:
Gender: Female
Age: 55 Years to 79 Years (Adult, Older Adult)
Location of Metastases:
Additional Notes: Patients must be between the ages of 55 and 79 years
Exclusions: Patients with active or unstable disease
https://ClinicalTrials.gov/show/NCT03612596